ATE127018T1 - Pharmazeutische zusammensetzung mit antiviraler und antibakterieller wirkung. - Google Patents

Pharmazeutische zusammensetzung mit antiviraler und antibakterieller wirkung.

Info

Publication number
ATE127018T1
ATE127018T1 AT93103246T AT93103246T ATE127018T1 AT E127018 T1 ATE127018 T1 AT E127018T1 AT 93103246 T AT93103246 T AT 93103246T AT 93103246 T AT93103246 T AT 93103246T AT E127018 T1 ATE127018 T1 AT E127018T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
antiviral
antibacterial action
antibacterial
bacterical
Prior art date
Application number
AT93103246T
Other languages
English (en)
Inventor
Zdzislaw Dr Fiutowski
Leszek Dr Fiutowski
Original Assignee
Fiutowski Zdzislaw
Fiutowski Leszek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fiutowski Zdzislaw, Fiutowski Leszek filed Critical Fiutowski Zdzislaw
Application granted granted Critical
Publication of ATE127018T1 publication Critical patent/ATE127018T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93103246T 1992-03-06 1993-03-01 Pharmazeutische zusammensetzung mit antiviraler und antibakterieller wirkung. ATE127018T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84732592A 1992-03-06 1992-03-06

Publications (1)

Publication Number Publication Date
ATE127018T1 true ATE127018T1 (de) 1995-09-15

Family

ID=25300338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93103246T ATE127018T1 (de) 1992-03-06 1993-03-01 Pharmazeutische zusammensetzung mit antiviraler und antibakterieller wirkung.

Country Status (4)

Country Link
US (1) US5527787A (de)
EP (1) EP0562306B1 (de)
AT (1) ATE127018T1 (de)
DE (1) DE69300409T2 (de)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806866C3 (de) * 1978-02-17 1981-02-12 Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld Verwendung von Salzen von Dithiodialkansulfonsäuren
US4334069A (en) * 1978-07-24 1982-06-08 Miles Laboratories, Inc. Chemiluminescent phthalhydrazide-labeled hapten conjugates
US4315851A (en) * 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
US4404366A (en) * 1980-05-06 1983-09-13 Miles Laboratories, Inc. Beta-galactosyl-umbelliferone-labeled hapten conjugates
US4842855A (en) * 1980-12-19 1989-06-27 University Of Pittsburgh Antitumor process using a Brucella abortus preparation
EP0086627B1 (de) * 1982-02-12 1985-08-28 Unitika Ltd. Antikrebsmittel
EP0095906B1 (de) * 1982-05-27 1986-10-22 National Research Development Corporation Verbindungen anwendbar in Strahlentherapie und Chemotherapie
JPS59186924A (ja) * 1983-04-08 1984-10-23 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤
US4625014A (en) * 1984-07-10 1986-11-25 Dana-Farber Cancer Institute, Inc. Cell-delivery agent
US4753788A (en) * 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
US5057313A (en) * 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
US5023172A (en) * 1986-07-14 1991-06-11 The Research Foundation Of State University Of New York Predictive assay for tumor control
US5001051A (en) * 1986-12-12 1991-03-19 Regents Of The University Of California Dose critical in-vivo detection of anti-cancer drug levels in blood
US4978332A (en) * 1987-09-28 1990-12-18 Matrix Pharmaceutical, Inc. Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs

Also Published As

Publication number Publication date
DE69300409D1 (de) 1995-10-05
DE69300409T2 (de) 1996-02-01
EP0562306B1 (de) 1995-08-30
EP0562306A1 (de) 1993-09-29
US5527787A (en) 1996-06-18

Similar Documents

Publication Publication Date Title
ES2078570T3 (es) Derivados de n-acil-alfa-aminoacidos.
DE69432027D1 (de) Verwendung von schilddrüsenhormone in ein medizinisches behandlungsverfahren
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
NO306655B1 (no) Anvendelse av GLA, DGLA eller LA ved fremstilling av et medisinsk preparat
DE59107331D1 (de) Flupirtin in Kombination mit Antiparkinsonika zur Bekämpfung von Muskelverspannungen
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
TW226333B (de)
DK0413528T3 (da) Amphotere præparater og polymere former af alphahydroxysyrer og deres terapeutiske anvendelse
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE3683333D1 (de) Mittel zur behandlung von akne vulgaris und deren herstellung.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DK0512883T3 (da) Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
DK0543178T3 (da) Fremgangsmåde til fremstilling af et virusfrit thrombinkoncentrat
IE871567L (en) Method for treating depression
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
ATE136896T1 (de) Piperidylmethyl substituierte chromanderivate als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
ATE127018T1 (de) Pharmazeutische zusammensetzung mit antiviraler und antibakterieller wirkung.
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DK0468351T3 (da) Ortopædisk terapisko og indersko
CA2129919A1 (en) Pharmaceutical Composition Having Antiviral and Antibacterial Activity and Method of Administration
DE69433221D1 (de) Neues Chondrozytprotein
DK15088D0 (da) Antibakterielt lyofiliseret praeparat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties